DJIA 16,501.65 -12.72 -0.08%
NASDAQ 4,126.97 0.00 0.00%
S&P 500 1,875.39 -4.16 -0.22%
market minute promo

303.08 -8.60 (-2.76%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

REGN $303.08 -2.76%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $312.36
Previous Close $311.68
Daily Range $301.87 - $312.88
52-Week Range $206.30 - $352.49
Market Cap $30.3B
P/E Ratio 81.81
Dividend (Yield) $0.00 (0.0%)
Volume 609,800
Average Daily Volume 1,149,429
Current FY EPS $4.38

Sector

Healthcare

Industry

Drugs

Regeneron Pharmaceuticals, Inc. (REGN) Description

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website: http://www.regeneron.com/

News & Commentary Rss Feed

Cholesterol-Lowering Drug Market Heats Up

This video discusses Amgen's evolocumab, Rengeneron Pharmaceuticals and Sanofi's alirocumab, and the rest of the PCSK9 inhibitors.

Bristol-Myers, Samsung BioLogics Extend Ties - Analyst Blog

Biogen's Q1 Earnings Soar Y/Y on Tecfidera Sales - Analyst Blog

Why Biogen (BIIB) Stock Is Down Today

Sarepta Soars on Eteplirsen Submission Plans - Analyst Blog

Should You Get Rid of Retrophin (RTRX) Now? - Tale of the Tape

Should You Get Rid of Retrophin (RTRX) Now? - Tale of the Tape

3 Stocks Reiterated As A Hold: PM, FSLR, REGN

Regeneron Pharmaceuticals Inc. (REGN): Today's Featured Health Care Winner

Nasdaq 100 Movers: LLTC, YHOO

UPDATE: Canaccord Genuity Initiates Coverage on Regeneron Pharmaceuticals on Expected Continued Pipe

UPDATE: Canaccord Genuity Initiates Coverage on Regeneron Pharmaceuticals on Expected Continued Pipeline Success

3 Stocks Reiterated As A Hold: TSLA, PM, REGN

See More REGN News...

REGN's Top Competitors

REGN $303.08 (-2.76%)
Current stock: REGN
AMGN $113.32 (-5.02%)
Current stock: AMGN
CELG $144.82 (-1.24%)
Current stock: CELG
GILD $73.86 (1.37%)
Current stock: GILD